Sequential effects of photodynamic treatment of basal cell carcinoma

Journal of Cutaneous Pathology

Volumn 36, Issue 4, 2009, Pages 409-416

  Prignano, Francesca ^a   Lotti, Torello ^a   Spallanzani, Adelina ^a   Berti, Samantha ^a   De Giorgi, Vincenzo ^a   Moretti, Silvia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER PATIENT; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KERATINOCYTE; MACROPHAGE; MAST CELL; PHAGOCYTE; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; SKIN BIOPSY;

AMINOLEVULINIC ACID; APOPTOSIS; CARCINOMA, BASAL CELL; CYTOKINES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFLAMMATION; MICROSCOPY, ELECTRON, TRANSMISSION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 61449091571     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2008.01063.x     Document Type: Article

References (29)

1. Walling HW, Fosko SW, Geraminejad PA, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004 23 : 389.
2. Morton CA, AacKie RM, Whitehurst C, Moore JV, McColl JH. Photodynamic therapy for basal cell carcinoma: effect of tumour thickness and duration of photosensitizer application on response. Arch Dermatol 1998 134 : 248.
3. Rittenhouse-Diakun K, Van Leengoed H, Morgan J, et al. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic aid (ALA). Photochem Photobiol 1995 61 : 23.
4. Oseroff A. PDT as a cytotoxic agent and biological response modifier: implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. J Invest Dermatol 2006 126 : 542.
5. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998 90 : 889.
6. Ahmad N, Gupta S, Feys DK, Mukhar H. Involvement of Fas (Apo-1/CD95) during photodynamic therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 2000 115 : 1041.
7. Prignano F, Bianchi B, Domenici L, et al. Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol 2003 149 : 205.
8. Moretti S, Pinzi C, Spallanzani A, et al. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999 84 : 160.
9. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002 146 : 552.
10. Wong TW, Tracy E, Oseroff AR, Baunmann H. Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Res 2003 63 : 3812.
11. Liu W, Oseroff AR, Baumann H. Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of ninterleukin-6 cytokine responsiveness in epithelial cells. Cancer Res 2004 64 : 6579.
12. Gambichler T, Skrygan M, Bechara F, Tomi NS, Altmeyer P, Kreuter A. Cytokine mRNA expression in basal cell carcinoma. Arch Dermatol Res 2006 298 : 139.
13. Krosl G, Korbelik M, Dougherty GJ. Induction of cell infiltration into murine SCCVII tumor by photofrin-based photodynamic therapy. Br J Cancer 1995 71 : 549.
14. Korbelik M, Dougherty GJ. Photodynamic therapy-mediated immune response against subcutaneous mouse tumor. Cancer Res 1999 59 : 1941.
15. Lan CC, Wu CS, Cheng CM, Yu CL, Chen GS, Yu HS. Pigmentation in basal cell carcinoma involves enhanced endothelin-1 expression. Exp Dermatol 2005 14 : 528.
16. Wong DA, Bishop GA, Lowes MA, Cooke B, Barneston RS, Halliday GM. Cytokine profiles in spontaneously regressing basal cell carcinomas. Br J Dermatol 2000 143 : 91.
17. Bowden J, Brennan PA, Umar T, Cronin A. Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck. J Cutan Pathol 2002 29 : 585.
18. Yamamoto T, Katayama I, Nishioka K. Expression of stem cell factor in basal cell carcinoma. Br J Dermatol 1997 137 : 709.
19. Yen HT, Chiang LC, Wen KH, et al. Arsenic induces interleukin-8 expression in cultured keratinocytes. Arch Dermatol Res 1996 288 : 716.
20. Oh CK, Kwon YW, Kim YS, Jang HS, Kwon KS. Expression of basic fibroblastic growth factor, vascular endothelial growth factor, and thrombospondi-1 related to microvessel density in nonaggressive and aggressive basal cell carcinomas. J Dermatol 2003 30 : 306.
21. Rampart M, van Damme J, Zonnekeyn L, Herman AG. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am J Pathol 1989 135 : 21.
22. Eksioglu EA, Mahmood SS, Chang M, Treddy V. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward predominantly type 1 proinflammatory response. Exp Hematol 2007 35 : 1163.
23. Okayama Y, Kawakami T. Development, migration and survival of mast cells. Immunol Res 2006 34 : 97.
24. Osiecka BJ, Piotr Z, Gamian E, et al. Determination of basic fibroblastic growth factor levels in serum of tumor-bearing BALB/c mice treated with photodynamic therapy. Pol J Pathol 2003 54 : 117.
25. Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ. Angiogenetic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 2000 60 : 4066.
26. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 2006 63 : 321.
27. Gollnick SO, Liu X, Owezarczak B, Musser DA, Hendersopn BW. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 1997 57 : 3904.
28. Wells T, Papoutsaki M, Michel G, et al. Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array. Int J Cancer 2003 104 : 66.
29. Alam R, Kumar D, Anderson-Walters D, Forsythe PA. Macrophage inflammatory protein-1 and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J Immunol 1994 152 : 1298.